Ipsen SA (EURONEXT:IPN) - Share price - Overview

Stock Report

Ipsen SA IPN

Last Price
110.20

Day Change
0.15|0.14%

As of 18/08/2017
17:35:00 CEST | EUR
Minimum 15 Minutes Delay.

Last Close110.05
Day Range108.30 - 110.55
Mkt Cap9.08Bil
52-Wk Range57.36 - 129.85
Yield %0.77
ISINFR0010259150
Volume92,651
P/E40.37
P/S5.45
P/CF28.65

Share Price

Financials
201420152016
More ...
Income Statement
Revenue1,332.401,520.201,671.10
Operating Income221.40244.00304.70
Net Income153.50189.90225.90
Basic EPS1.872.312.74
Avg. Diluted Shares Outstanding828383
Balance Sheet
Current Assets671.60809.901,050.40
Non Current Assets1,041.701,128.101,373.10
Total Assets1,713.301,938.002,423.50
Current Liabilities410.20461.50561.30
Total Liabilities648.10715.501,064.60
Total Equity1,065.201,222.501,358.90
Cash Flow
Operating Cash Flow245.80223.60317.80
Capital Expenditure-84.40-75.20-372.30
Free Cash Flow161.40148.40-54.50

In millions, except "Basic EPS". Currency is EUR.

Company Profile

Ipsen SA is a pharmaceutical company. The company mainly develops and manufactures products to serve the oncology, endocrinology, neurosciences, and primary care areas mainly across the European markets.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Stock Style

Large-Growth

Fiscal Year Ends

December

Employees

4,907
Key Stats
More ...
Price/Earning TTM40.16
Price/Book6.67
Price/Sales TTM5.44
Rev Growth (3 year avg)9.24
EPS Growth (3 year avg)-
Operating Margin % TTM18.23
Net Margin % TTM13.52
ROE TTM17.50
Debt/Equity0.22
Dividends
PreviousLatest
More ...
Declared Date13/04/1620/04/17
Ex-Div02/06/1609/06/17
Paid06/06/1613/06/17
Amnt0.850.85
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.